You are here: Industry Insights > COVID-19 Vaccine

News List

UK’s SARS-CoV-2 vaccine candidate is safe and induces antibody and T cell response europeanpharmaceuticalreview
July 22, 2020
Data released from the Phase I/II trial of the ChAdOx1 COVID-19 vaccine candidate suggests it elicits an immune response with no adverse effects.
Oxford COVID-19 vaccine developer cautious on 2020 roll-out expresspharma
July 22, 2020
The experimental vaccine, which has been licensed to AstraZeneca, produced an immune response in early-stage clinical trials, preserving hopes it could be in use by the end of 2020.
Serum to apply for local trials on Oxford’s vaccine in a week: CEO expresspharma
July 22, 2020
SII, the largest vaccine manufacturer in the world, has been chosen by Oxford and its partner AstraZeneca to manufacture the vaccine once it gets ready.
COVID-19 vaccine AZD1222 showed robust immune responses in all participants in Phase I/II trial worldpharmanews
July 21, 2020
Interim results from the ongoing Phase I/II COV001 trial, led by Oxford University, showed AZD1222 was tolerated and generated robust immune responses against the SARS-CoV-2 virus in all evaluated participants.
UK Government secures early access to 90 million doses of COVID-19 vaccines europeanpharmaceuticalreview
July 21, 2020
The government has entered partnerships with Pfizer and Valneva to secure doses of several promising COVID-19 vaccines and secured COVID-19 neutralising antibody treatments from AstraZeneca.
UK enters supply agreement for Pfizer and BioNTech’s Covid-19 vaccine pharmaceutical-technology
July 21, 2020
The UK Government has signed an agreement with Pfizer and BioNTech for the supply of 30 million doses of the companies’ mRNA-based Covid-19 vaccine candidate, BNT162.
China’s indigenously developed COVID-19 vaccines set to surprise the world: GlobalData expresspharma
July 21, 2020
China's Sinopharm and Sinovac (in collaboration with Brazil-based Butantan) have both reported encouraging results in the early phases of human testing for COVID-19.
Russia to mass produce experimental COVID-19 vaccine – wealth fund head expresspharma
July 21, 2020
A larger Phase III trial involving several thousand people is expected to begin in August, said Russian Direct Investment Fund (RDIF) head Kirill Dmitriev.
China’s Sinopharm begins late stage trial of COVID-19 vaccine in UAE expresspharma
July 20, 2020
The human trial is a partnership between Sinopharm’s China National Biotec Group (CNBG), Abu Dhabi-based artificial intelligence and cloud computing company Group 42 (G42) and the Abu Dhabi Department of Health.
China gives the go-ahead for human trials of BioNTech’s COVID vaccine candidate expresspharma
July 20, 2020
China has approved an early-stage trial in humans of German firm BioNTech’s experimental COVID-19 vaccine, its local partner Shanghai Fosun Pharmaceutical said.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page